Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Opsens Inc. currently manages 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. This prosecution activity is distributed across 2 distinct examiners, indicating that the pending actions are shared between multiple individuals. All of these matters are concentrated within 1 distinct art unit, which suggests a specific technological scope for the company's current patent applications. This concentration allows for a specialized approach to prosecution within an individual administrative division of the patent office.
The busiest examiner for this portfolio is CELESTINE, NYROBI I, who is responsible for 1 pending office action. Because this examiner handles this 1 action, the workload is distributed across the 2 distinct examiners involved. Practitioners should note that the concentration in 1 distinct art unit may lead to consistent examination patterns across the portfolio despite the involvement of different individuals. The presence of 2 distinct examiners for the pending actions means that no individual examiner currently holds all of the workload for Opsens Inc.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §102 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CELESTINE, NYROBI I | 1 | 81.4% | +23.1% |
| WEARE, MEREDITH H | 1 | 50.4% | +31.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19163065 | METHOD AND SYSTEM FOR DETERMINING HEMODYNAMIC PARAMETERS | CELESTINE, NYROBI I | 41d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18849292 | PRESSURE BASED STRUCTURAL HEART ASSESSMENT SYSTEMS AND METHODS | WEARE, MEREDITH H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19163065 | METHOD AND SYSTEM FOR DETERMINING HEMODYNAMIC PARAMETERS | CELESTINE, NYROBI I | 41d |
| 18849292 | PRESSURE BASED STRUCTURAL HEART ASSESSMENT SYSTEMS AND METHODS | WEARE, MEREDITH H | — |
| Art Unit | Apps |
|---|---|
| 3798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19163065 | METHOD AND SYSTEM FOR DETERMINING HEMODYNAMIC PARAMETERS | CELESTINE, NYROBI I | 3798 | §102 | Final Rejection | 41d | Pending | Sep 08, 2025 |
| 18849292 | PRESSURE BASED STRUCTURAL HEART ASSESSMENT SYSTEMS AND METHODS | WEARE, MEREDITH H | — | §101§103 | Non-Final OA | — | Pending | Sep 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial